Tandem Diabetes Care Inc - Common Stock (TNDM)
CUSIP: 875372203
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 68,605,637
- Total 13F shares
- 67,061,755
- Share change
- -893,517
- Total reported value
- $1,645,737,206
- Put/Call ratio
- 148%
- Price per share
- $24.54
- Number of holders
- 242
- Value change
- -$59,226,945
- Number of buys
- 123
- Number of sells
- 147
Quarterly Holders Quick Answers
What is CUSIP 875372203?
CUSIP 875372203 identifies TNDM - Tandem Diabetes Care Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 875372203:
Top shareholders of TNDM - Tandem Diabetes Care Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
13%
|
9,207,560
|
$373,919,013 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
12%
|
8,239,730
|
$334,615,425 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
7,047,477
|
$286,198,040 | — | 31 Mar 2023 | |
| Capital World Investors |
13F
|
Company |
8.7%
|
5,956,530
|
$241,894,683 | — | 31 Mar 2023 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
4.8%
|
3,273,113
|
$132,921,119 | — | 31 Mar 2023 | |
| EMINENCE CAPITAL, LP |
13F
|
Company |
3.6%
|
2,469,657
|
$100,292,771 | — | 31 Mar 2023 | |
| BROWN CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.2%
|
2,170,773
|
$88,155,092 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
2,066,929
|
$83,937,987 | — | 31 Mar 2023 | |
| Bellevue Group AG |
13F
|
Company |
2.6%
|
1,793,763
|
$72,844,716 | — | 31 Mar 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
1,294,244
|
$52,558,503 | — | 31 Mar 2023 | |
| Capital International Investors |
13F
|
Company |
1.8%
|
1,259,967
|
$51,167,260 | — | 31 Mar 2023 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
1.5%
|
1,029,997
|
$41,828,178 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.5%
|
1,023,393
|
$41,559,990 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
936,677
|
$38,038,467 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
931,772
|
$37,839,281 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.3%
|
922,483
|
$37,462,035 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.86%
|
590,580
|
$23,983,453 | — | 31 Mar 2023 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.86%
|
589,185
|
$23,926,803 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.81%
|
557,912
|
$22,656,806 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
484,624
|
$19,680,581 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.7%
|
483,341
|
$19,628,000 | — | 31 Mar 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.69%
|
474,929
|
$19,286,867 | — | 31 Mar 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.66%
|
454,550
|
$18,460,000 | — | 31 Mar 2023 | |
| Eagle Health Investments LP |
13F
|
Company |
0.62%
|
425,525
|
$17,280,570 | — | 31 Mar 2023 | |
| Tri Locum Partners LP |
13F
|
Company |
0.61%
|
417,448
|
$16,952,563 | — | 31 Mar 2023 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.58%
|
398,865
|
$16,197,908 | — | 31 Mar 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.56%
|
387,613
|
$15,740,965 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
364,138
|
$14,787,644 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.51%
|
348,447
|
$14,150,432 | — | 31 Mar 2023 | |
| Chicago Capital, LLC |
13F
|
Company |
0.44%
|
302,990
|
$12,304,433 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.43%
|
297,940
|
$12,099,343 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.43%
|
294,904
|
$11,976,000 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.43%
|
293,277
|
$11,909,979 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.42%
|
291,191
|
$11,826,000 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.42%
|
287,487
|
$11,667,081 | — | 31 Mar 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.41%
|
280,192
|
$11,378,597 | — | 31 Mar 2023 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.38%
|
262,943
|
$10,678,115 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.37%
|
255,435
|
$10,373,216 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.36%
|
250,000
|
$10,152,500 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.36%
|
247,268
|
$10,041,553 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.36%
|
245,567
|
$9,972,476 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.36%
|
244,583
|
$9,932,515 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
0.35%
|
241,740
|
$9,817,061 | — | 31 Mar 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
224,408
|
$9,113,208 | — | 31 Mar 2023 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.3%
|
205,694
|
$8,353,233 | — | 31 Mar 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.3%
|
203,300
|
$8,256,013 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.28%
|
191,405
|
$7,772,955 | — | 31 Mar 2023 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.28%
|
190,516
|
$7,736,855 | — | 31 Mar 2023 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.27%
|
187,713
|
$7,623,025 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.27%
|
187,322
|
$7,607,146 | — | 31 Mar 2023 |
Institutional Holders of Tandem Diabetes Care Inc - Common Stock (TNDM) as of Q2 2023
As of 30 Jun 2023,
Tandem Diabetes Care Inc - Common Stock (TNDM) was held by
242 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,061,755 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, FMR LLC, EMINENCE CAPITAL, LP, STATE STREET CORP, Bellevue Group AG, JANUS HENDERSON GROUP PLC, Champlain Investment Partners, LLC, and BROWN CAPITAL MANAGEMENT LLC.
This page lists
243
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
270
Q2 2023 holders
242
Holder diff
-28
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.